| The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism MA Silvers, S Deja, N Singh, RA Egnatchik, J Sudderth, X Luo, MS Beg, ... Journal of Biological Chemistry 292 (44), 18203-18216, 2017 | 81 | 2017 |
| NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers EABDAB Edward A. Motea, Xiumei Huang, Naveen Singh, Jessica A Kilgore ... Clinical Cancer Research, 2019 | 37 | 2019 |
| Targeting NAD+ metabolism to enhance radiation therapy responses JE Lewis, N Singh, RJ Holmila, BD Sumer, NS Williams, CM Furdui, ... Seminars in radiation oncology 29 (1), 6-15, 2019 | 24 | 2019 |
| Heterogeneous multi-processing quad-core CPU and dual-GPU design for optimal performance, power, and thermal tradeoffs in a 28nm mobile application processor A Wang, T Lin, S Ouyang, W Huang, J Wang, S Chang, S Chen, C Hu, ... ISSCC Dig. Tech. Papers, 180-181, 2014 | 21 | 2014 |
| Modulators of redox metabolism in head and neck cancer X Chen, J Mims, X Huang, N Singh, E Motea, SM Planchon, M Beg, ... Antioxidants & Redox Signaling 29 (16), 1660-1690, 2018 | 18 | 2018 |
| MTHFD2 blockade enhances the efficacy of β-lapachone chemotherapy with ionizing radiation in head and neck squamous cell cancer K Shukla, N Singh, JE Lewis, AW Tsang, DA Boothman, ML Kemp, ... Frontiers in Oncology 10, 536377, 2020 | 16 | 2020 |
| β-Naphthoflavone-Induced Mitochondrial Respiratory Damage in Cyp1 Knockout Mouse and in Cell Culture Systems: Attenuation by Resveratrol Treatment SK Anandasadagopan, NM Singh, H Raza, S Bansal, V Selvaraj, S Singh, ... Oxidative Medicine and Cellular Longevity 2017, 2017 | 16 | 2017 |
| Therapeutic strategies and biomarkers to modulate PARP activity for targeted cancer therapy N Singh, SL Pay, SB Bhandare, U Arimpur, EA Motea Cancers 12 (4), 972, 2020 | 15 | 2020 |
| Targeting base excision repair in cancer: NQO1-bioactivatable drugs improve tumor selectivity and reduce treatment toxicity through radiosensitization of human cancer CL Starcher, SL Pay, N Singh, IJ Yeh, SB Bhandare, X Su, X Huang, ... Frontiers in Oncology 10, 1575, 2020 | 13 | 2020 |
| Following anticancer drug activity in cell lysates with DNA devices D Kahanda, N Singh, DA Boothman, JD Slinker Biosensors and Bioelectronics 119, 1-9, 2018 | 12 | 2018 |
| XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition PL Patidar, T Viera, JC Morales, N Singh, EA Motea, M Khandelwal, ... Scientific reports 10 (1), 14253, 2020 | 10 | 2020 |
| Mainuddin; Khan, T.; Kumar, S. A dual polarized multiband rectenna for RF energy harvesting. AEU-Int N Singh, BK Kanaujia, MT Beg J. Electron. Commun 93, 123-131, 2018 | 8 | 2018 |
| Detecting attomolar DNA-damaging anticancer drug activity in cell lysates with electrochemical DNA devices AP Wettasinghe, N Singh, CL Starcher, CC DiTusa, Z Ishak-Boushaki, ... ACS sensors 6 (7), 2622-2629, 2021 | 5 | 2021 |
| Monophasic synovial sarcoma of posterior pharyngeal wall: a rare case report with unique reconstruction using lateral trapezius flap M Agarwal, A Singh, A Abrari, N Singh European Archives of Oto-Rhino-Laryngology 274, 2059-2064, 2017 | 5 | 2017 |
| PDE5 inhibitors offer novel mechanisms in combination and solo cancer therapy RW Lyday, AM Etters, C Kim, F Magana, GM Pontipiedra, NKM Singh, ... Current Cancer Therapy Reviews 13 (2), 107-119, 2017 | 3 | 2017 |
| Inhibition of CYP2S1 mediated metabolism of anticancer prodrug AQ4N by liarozole NKM Singh, SR White, S Kalagara, S Kadavakollu Journal of Applied Pharmaceutical Science 7 (2), 001-007, 2017 | 3 | 2017 |
| Computational Intelligence in Circuit Synthesis through Evolutionary Algorithms and Particle Swarm Optimization N Singh, H Chaturvedi, K Honey International Journal of Advances in Engineering & Technology 1 (2), 198, 2011 | 2 | 2011 |
| Inherited prion disease: molecular pathology and cell models. P Parchi, S Capellari, G Zanusso, N Singh, P Gambetti, RP Petersen Prions: molecular and cell biology: current innovations., 67-86, 1999 | 2 | 1999 |
| Utility and relevance of modified lateral trapezius myocutaneous flap as a locoregional reconstructive option for medium-sized ablative defects in head and neck cancer—our … A Singh, M Agarwal, N Singh, H Chaturvedi, M Venkatasubramaniyan, ... European Archives of Oto-Rhino-Laryngology 277, 2539-2549, 2020 | | 2020 |
| Role of b‐lapachone treatment mediated base excision repair protein PARylation in colorectal cancer cells. N Singh The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
